FIELD: organic chemistry, pharmacy. SUBSTANCE: invention relates to (R)-(methylaminosulfonylmethyl)-3-(N-methyl- pyrrolidine-2-ylmethyl)-1H-indole fumarate of the formula (I) . The end product is prepared by interaction of compound (I) with fumaric acid. Compound (I) fumarate can be used in pharmaceutical composition for migraine treatment. Compound (I) fumarate is resistant to oxidative decomposition, shows excellent solubility, resistance in the solid state and absence of hygroscopicity. EFFECT: improved method of preparing, valuable physical properties. 5 cl, 3 tbl, 1 dwg
Authors
Dates
2001-01-10—Published
1996-04-10—Filed